Entheon Biomedical Corp. (ENTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0690
-0.0110 (-13.75%)
Aug 22, 2025, 4:00 PM EDT
Entheon Biomedical Market Cap
Entheon Biomedical has a market cap or net worth of $947.57 thousand as of August 22, 2025. Its market cap has increased by 8.39% in one year.
Market Cap
947.57K
Enterprise Value
652.93K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since November 12, 2020, Entheon Biomedical's market cap has decreased from 18.81M to 947.57K, a decrease of -94.96%. That is a compound annual growth rate of -46.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 947.57K | -16.80% |
| Dec 30, 2024 | 1.14M | 154.54% |
| Dec 29, 2023 | 447.43K | -48.76% |
| Dec 30, 2022 | 873.18K | -94.25% |
| Dec 31, 2021 | 15.18M | -55.24% |
| Dec 31, 2020 | 33.90M | 80.26% |
| Nov 12, 2020 | 18.81M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 633.65M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 594.33M |
| American Oncology Network | 385.33M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 367.18M |